{"name": "CureDM",
 "permalink": "curedm",
 "crunchbase_url": "http://www.crunchbase.com/company/curedm",
 "homepage_url": "http://www.curedm.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "contact@curedm.com",
 "phone_number": "302-288-0620",
 "description": "",
 "created_at": "Thu Apr 29 05:19:20 UTC 2010",
 "updated_at": "Thu Apr 29 05:29:48 UTC 2010",
 "overview": "\u003Cp\u003ECureDM is a biopharmaceutical company established to develop new therapies that may prevent, ameliorate or reverse diabetes and allow for the discontinuation of insulin.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       75],
      "assets/images/resized/0008/5278/85278v1-max-150x150.jpg"],
     [[182,
       91],
      "assets/images/resized/0008/5278/85278v1-max-250x250.jpg"],
     [[182,
       91],
      "assets/images/resized/0008/5278/85278v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$2.5M",
 "funding_rounds":
  [{"round_code": "b",
    "source_url": "http://www.curedm.com/news/2006.11.30_curedm_press_release.pdf",
    "source_description": "CureDM, Inc. Announces the Closing of a Series B Stock Placement",
    "raised_amount": 2500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2006,
    "funded_month": 11,
    "funded_day": 30,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Scientific Health Development Partners",
         "permalink": "scientific-health-development-partners",
         "image":
          {"available_sizes":
            [[[150,
               83],
              "assets/images/resized/0008/5280/85280v1-max-150x150.jpg"],
             [[222,
               123],
              "assets/images/resized/0008/5280/85280v1-max-250x250.jpg"],
             [[222,
               123],
              "assets/images/resized/0008/5280/85280v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Calvert Research Institute",
         "permalink": "calvert-research-institute",
         "image":
          {"available_sizes":
            [[[150,
               29],
              "assets/images/resized/0008/5281/85281v1-max-150x150.jpg"],
             [[250,
               49],
              "assets/images/resized/0008/5281/85281v1-max-250x250.jpg"],
             [[450,
               89],
              "assets/images/resized/0008/5281/85281v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "1201 N. Market St., Suite 701",
    "address2": "",
    "zip_code": "19801",
    "city": "Wilmington",
    "state_code": "DE",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        114],
       "assets/images/resized/0008/5279/85279v1-max-150x150.jpg"],
      [[250,
        190],
       "assets/images/resized/0008/5279/85279v1-max-250x250.jpg"],
      [[450,
        343],
       "assets/images/resized/0008/5279/85279v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}